Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro

Latency-reversing agents (LRAs) are considered a potential tool to cure human immunodeficiency virus type 1 (HIV-1) infection, but when they are taken alone, virus production by reactivated cells and subsequent infection will occur. Hence, it is crucial to simultaneously take appropriate measures to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Shin-ichiro, Matsuda, Kouki, Tsuchiya, Kiyoto, Gatanaga, Hiroyuki, Oka, Shinichi, Yoshimura, Kazuhisa, Mitsuya, Hiroaki, Maeda, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156138/
https://www.ncbi.nlm.nih.gov/pubmed/30283406
http://dx.doi.org/10.3389/fmicb.2018.02022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156138/
https://www.ncbi.nlm.nih.gov/pubmed/30283406
http://dx.doi.org/10.3389/fmicb.2018.02022

Ejemplares similares